Literature DB >> 28146011

PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.

Alison E Fohner1, Alex Sparreboom, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28146011      PMCID： PMC5346035          DOI： 10.1097/FPC.0000000000000270

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  24 in total

1.  The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.

Authors:  Daniel Kurnik; Alastair J J Wood; Grant R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  2006-09       Impact factor: 6.875

2.  Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline).

Authors:  Jerry M Zuckerman; Fozia Qamar; Bartholomew R Bono
Journal:  Med Clin North Am       Date:  2011-07       Impact factor: 5.456

Review 3.  Azithromycin.

Authors:  Ahmed H H Bakheit; Badraddin M H Al-Hadiya; Ahmed A Abd-Elgalil
Journal:  Profiles Drug Subst Excip Relat Methodol       Date:  2014

4.  Comparison of the acid stability of azithromycin and erythromycin A.

Authors:  E F Fiese; S H Steffen
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

5.  The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3.

Authors:  Annick Seithel; Sonja Eberl; Katrin Singer; Daniel Auge; Georg Heinkele; Nadine B Wolf; Frank Dörje; Martin F Fromm; Jörg König
Journal:  Drug Metab Dispos       Date:  2007-02-12       Impact factor: 3.922

Review 6.  Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.

Authors:  Jerry M Zuckerman
Journal:  Infect Dis Clin North Am       Date:  2004-09       Impact factor: 5.982

7.  The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Authors:  L B Ramsey; S G Johnson; K E Caudle; C E Haidar; D Voora; R A Wilke; W D Maxwell; H L McLeod; R M Krauss; D M Roden; Q Feng; R M Cooper-DeHoff; L Gong; T E Klein; M Wadelius; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2014-06-11       Impact factor: 6.875

Review 8.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

9.  DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Savita Shrivastava; Murtaza Hassanali; Paul Stothard; Zhan Chang; Jennifer Woolsey
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

Review 10.  A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Authors:  Lorena Baietto; Silvia Corcione; Giovanni Pacini; Giovanni Di Perri; Antonio D'Avolio; Francesco Giuseppe De Rosa
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731
View more
  12 in total

Review 1.  Pharmacogenomics of COVID-19 therapies.

Authors:  Takuto Takahashi; Jasmine A Luzum; Melanie R Nicol; Pamala A Jacobson
Journal:  NPJ Genom Med       Date:  2020-08-18       Impact factor: 8.617

Review 2.  Mechanism of action, resistance, synergism, and clinical implications of azithromycin.

Authors:  Mohsen Heidary; Ahmad Ebrahimi Samangani; Abolfazl Kargari; Aliakbar Kiani Nejad; Ilya Yashmi; Moloudsadat Motahar; Elahe Taki; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

Review 3.  Cardiovascular manifestations and treatment considerations in COVID-19.

Authors:  Yu Kang; Tiffany Chen; David Mui; Victor Ferrari; Dinesh Jagasia; Marielle Scherrer-Crosbie; Yucheng Chen; Yuchi Han
Journal:  Heart       Date:  2020-04-30       Impact factor: 5.994

Review 4.  Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.

Authors:  Abhjieet Pandey; Ajinkya Nitin Nikam; Ajjappla Basavaraj Shreya; Sadhana P Mutalik; Divya Gopalan; Sanjay Kulkarni; Bharath Singh Padya; Gasper Fernandes; Srinivas Mutalik; Ruth Prassl
Journal:  Life Sci       Date:  2020-06-01       Impact factor: 5.037

5.  Catchment-scale export of antibiotic resistance genes and bacteria from an agricultural watershed in central Iowa.

Authors:  Timothy P Neher; Lanying Ma; Thomas B Moorman; Adina C Howe; Michelle L Soupir
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

Review 6.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

Review 7.  Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.

Authors:  Rami A Al-Horani; Srabani Kar; Kholoud F Aliter
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

Review 8.  Equine Drug Transporters: A Mini-Review and Veterinary Perspective.

Authors:  Brielle Rosa
Journal:  Pharmaceutics       Date:  2020-11-08       Impact factor: 6.321

9.  Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.

Authors:  Dimitri Poddighe; Mohamad Aljofan
Journal:  Antivir Chem Chemother       Date:  2020 Jan-Dec

Review 10.  Pharmacogenomics of COVID-19 therapies.

Authors:  Takuto Takahashi; Jasmine A Luzum; Melanie R Nicol; Pamala A Jacobson
Journal:  NPJ Genom Med       Date:  2020-08-18       Impact factor: 8.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.